| Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism J Lee, AE Yesilkanal, JP Wynne, C Frankenberger, J Liu, J Yan, M Elbaz, ... Nature 568 (7751), 254-258, 2019 | 278 | 2019 |
| Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer M Elbaz, MW Nasser, J Ravi, NA Wani, DK Ahirwar, H Zhao, S Oghumu, ... Molecular oncology 9 (4), 906-919, 2015 | 233 | 2015 |
| RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment MW Nasser, NA Wani, DK Ahirwar, CA Powell, J Ravi, M Elbaz, H Zhao, ... Cancer research 75 (6), 974-985, 2015 | 148 | 2015 |
| Statins as anticancer agents in the era of precision medicine J Longo, JE van Leeuwen, M Elbaz, E Branchard, LZ Penn Clinical Cancer Research 26 (22), 5791-5800, 2020 | 136 | 2020 |
| Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation DK Ahirwar, MW Nasser, MM Ouseph, M Elbaz, MC Cuitiño, RD Kladney, ... Oncogene 37 (32), 4428-4442, 2018 | 117 | 2018 |
| TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer M Elbaz, D Ahirwar, Z Xiaoli, X Zhou, M Lustberg, MW Nasser, K Shilo, ... Oncotarget 9 (71), 33459, 2018 | 87 | 2018 |
| Cannabinoid receptor‐2 agonist inhibits macrophage induced EMT in non‐small cell lung cancer by downregulation of EGFR pathway J Ravi, M Elbaz, NA Wani, MW Nasser, RK Ganju Molecular carcinogenesis 55 (12), 2063-2076, 2016 | 75 | 2016 |
| Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer M Elbaz, D Ahirwar, J Ravi, MW Nasser, RK Ganju Oncotarget 8 (18), 29668, 2017 | 58 | 2017 |
| A pilot window-of-opportunity study of preoperative fluvastatin in localized prostate cancer J Longo, RJ Hamilton, M Masoomian, N Khurram, E Branchard, PJ Mullen, ... Prostate cancer and prostatic diseases 23 (4), 630-637, 2020 | 46 | 2020 |
| Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins MW Nasser, M Elbaz, DK Ahirwar, RK Ganju Cancer letters 365 (1), 11-22, 2015 | 43 | 2015 |
| STAT1 gene deficient mice develop accelerated breast cancer growth and metastasis which is reduced by IL-17 blockade S Varikuti, S Oghumu, M Elbaz, G Volpedo, DK Ahirwar, PC Alarcon, ... Oncoimmunology 6 (11), e1361088, 2017 | 40 | 2017 |
| Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced N-glycosylation Abundance and Branching R Yu, J Longo, JE van Leeuwen, C Zhang, E Branchard, M Elbaz, ... Cancer research 81 (10), 2625-2635, 2021 | 29 | 2021 |
| Profile of palbociclib in the treatment of metastatic breast cancer M Ehab, M Elbaz Breast Cancer: Targets and Therapy, 83-91, 2016 | 27 | 2016 |
| Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation DZ Dos Santos, M Elbaz, E Branchard, W Schormann, CE Brown, ... Biomedicine & Pharmacotherapy 177, 116934, 2024 | | 2024 |
| Validation of the OncoMate MSI Dx Analysis System (Promega) J Schroeder, M Elbaz, J Lavik, J Sen, R Sperling JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S127-S127, 2023 | | 2023 |
| Validation of RNA Extraction from Whole Peripheral Blood Using the Maxwell CSC RNA Blood Kit (Promega) on the Maxwell CSC 48 Instrument (Promega) R Gorden, R Sperling, M Elbaz, J Lavik JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S42-S42, 2023 | | 2023 |
| Abstract B073: Inhibiting prostate cancer by targeting the metabolic mevalonate pathway DZ Santos, M Elbaz, E Branchard, W Schormann, DW Andrews, LZ Penn Cancer Research 83 (11_Supplement), B073-B073, 2023 | | 2023 |
| Effective combination therapy for breast cancer targeting BACH1 and mitochondrial metabolism J Lee, A Yesilkanal, C Frankenberger, M Elbaz, D Rabe, J Yan, ... Cancer Research 78 (13_Supplement), 5497-5497, 2018 | | 2018 |
| S-100 Proteins M Elbaz, G Amponsah, RK Ganju, MW Nasser, ... | | 2017 |
| Novel role of CB2R in tuning breast tumor microenvironment, EGF/EGFR and IGF-I/IGF-IR pathways M Elbaz, M Nasser, J Ravi, D Ahirwar, R Ganju Cancer Research 76 (14_Supplement), 729-729, 2016 | | 2016 |
